Llwytho...
Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet’s Disease
Intestinal Behçet’s disease is a rare, immune-mediated chronic intestinal inflammatory disease; therefore, clinical trials to optimize the management and treatment of patients are scarce. Moreover, intestinal Behçet’s disease is difficult to treat and often requires surgery because of the failure of...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Gut Liver |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Editorial Office of Gut and Liver
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6254627/ https://ncbi.nlm.nih.gov/pubmed/29788675 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl17462 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|